Bulletin
Investor Alert

Denali Therapeutics Inc.

NAS: DNLI

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Mar 31, 2023, 5:37 p.m.

/zigman2/quotes/200043077/composite

$

22.58

Change

-0.46 -2.00%

Volume

Volume 42,638

Quotes are delayed by 20 min

/zigman2/quotes/200043077/composite

Previous close

$ 21.91

$ 23.04

Change

+1.13 +5.16%

Day low

Day high

$21.96

$23.11

Open

52 week low

52 week high

$20.24

$39.43

Open

Vicki L. Sato

Vicki L. Sato is Non-Executive Chairman of Denali Therapeutics, Inc., Non-Executive Chairman at Vir Biotechnology, Inc. and Venture Partner at ARCH Venture Partners LLC. She is also on the board of Prize4Life, Inc., Peer Health Exchange and Allogene Therapeutics, Inc. and Member-Overseers Board at The Isabella Stewart Gardner Museum, Inc.

In her past career Dr. Sato held the position of President of Vertex Pharmaceuticals, Inc., Vice President-Research at Biogen, Inc., Business Advisor at Atlas Ventures Advisors, Inc., Member-Scientific Counselors Board at The Broad Institute, Inc., Advisor at BioVentures Investors, Professor at Harvard University and Professor at Harvard Business School.

She received a doctorate and a graduate degree from Harvard University and an undergraduate degree from Radcliffe College.

Transactions

Date Shares Transaction Value
06/02/2022 5,986   Award at $0 per share. 0
11/10/2021 660   Disposition at $53.3 per share. 35,178
11/10/2021 1,006   Disposition at $52.49 per share. 52,805
11/01/2021 1,666   Disposition at $50.05 per share. 83,384
09/15/2021 140   Disposition at $54.76 per share. 7,667
09/15/2021 620   Disposition at $53.92 per share. 33,431
09/15/2021 676   Disposition at $53.03 per share. 35,849
09/15/2021 230   Disposition at $52.28 per share. 12,025
08/18/2021 860   Disposition at $52.12 per share. 44,824
08/18/2021 806   Disposition at $51.26 per share. 41,316
07/21/2021 400   Disposition at $65.78 per share. 26,312
07/21/2021 866   Disposition at $65.24 per share. 56,498
07/21/2021 400   Disposition at $64.25 per share. 25,700
06/23/2021 986   Disposition at $71.1 per share. 70,105
06/23/2021 680   Disposition at $70.2 per share. 47,736
06/02/2021 2,074   Award at $0 per share. 0
05/26/2021 40   Disposition at $66.72 per share. 2,669
05/26/2021 732   Disposition at $65.88 per share. 48,225
05/26/2021 894   Disposition at $64.9 per share. 58,021
04/28/2021 688   Disposition at $63.03 per share. 43,365
04/28/2021 597   Disposition at $62.05 per share. 37,044
04/28/2021 381   Disposition at $60.71 per share. 23,131
03/31/2021 136   Disposition at $57.61 per share. 7,835
03/31/2021 635   Disposition at $56.92 per share. 36,145
03/31/2021 877   Disposition at $55.91 per share. 49,034
03/31/2021 18   Disposition at $54.38 per share. 979
03/03/2021 115   Disposition at $63.36 per share. 7,287
03/03/2021 266   Disposition at $62.29 per share. 16,570
03/03/2021 1,050   Disposition at $61.52 per share. 64,596
03/03/2021 235   Disposition at $60.36 per share. 14,185

Officers and Executives

Dr. Ryan J. Watts
President, Chief Executive Officer & Director
Dr. Alexander O. Schuth
Secretary, Chief Operating & Financial Officer
Dr. Joe Lewcock
Chief Scientific Officer
Dr. Carole Ho
Chief Medical Officer & Head-Development
Dr. Dana Andersen
CTO & Chief Manufacturing Officer
Ms. Katie Peng
Chief Commercial Officer
Mr. Steve E. Krognes
Director
Dr. Laura G. Hansen
Vice President-Investor Relations
Ms. Cindy Dunkle
Chief People Officer
Dr. Chris Walsh
Associate General Counsel
Ms. Erica Kratz
Vice President-Regulatory
Dr. Vicki L. Sato
Non-Executive Chairman
Ms. Nancy A. Thornberry
Independent Director
Mr. Erik C. Harris
Independent Director
Dr. Marc Tessier-Lavigne
Independent Director
Dr. Douglas G. Cole
Independent Director
Mr. Jay T. Flatley
Independent Director
Dr. David Paul Schenkein
Independent Director
Mr. Peter S. Klein
Independent Director
Ms. Jennifer E. Cook
Independent Director
Link to MarketWatch's Slice.